Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Chondroitin
Selected research topic
Bone, joint, and mobility
Findings differ across measurements or study conditions. The results below keep them separate.
Findings from a combination study cannot be attributed to this ingredient alone.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 12
- Human comparison publications
- 2
- Publications needing review
- 9
Findings in the studies
BML scores
- A better result than the comparison group was reported.Patient group · Single ingredient · 12 months
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: chondroitin versus placebo through month 6; open-label thereafter
- Additional measurement information
- Biomarker
- Measurement time
- 12 months
cartilage volume loss
- A better result than the comparison group was reported.
What the comparison group used was not confirmed.
Patient group · Single ingredientMeasurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups.
- Measurement time
- Not confirmed.
TKRs
- No clear difference from the comparison group was found.Patient group · Single ingredient · 4-year follow-up
Measurement and study conditions
- Study type
- Controlled trial
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: post hoc long-term comparison of prior CS versus placebo assignment
- Measurement time
- 4-year follow-up
cartilage volume
Research with unclear study subject or type
- No clear difference in this measurement was found between the compared groups.
What the comparison group used was not confirmed.
Single ingredientMeasurement and study conditions
- Study type
- Meta-analysis
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups.
- Measurement time
- Not confirmed.
Other measured outcomes (1)
pain during activity
Research with unclear study subject or type
- The study reported improvement in this measurement.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
Combination study · 3–6 monthsMeasurement and study conditions
- Study type
- Meta-analysis
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Ingredient combination
- How results were compared
- Results were compared between groups. · Study comparison: specific Structum chondroitin sulfate preparation versus placebo
- Additional measurement information
- Primary outcome
- Measurement time
- 3–6 months
This result is held for interpretation. That does not mean research found no effect.
Outcome groups needing additional review (5)
- joint space narrowing · Distinct papers needing additional review: 1Direction unclear: 1
- knee pain · Distinct papers needing additional review: 1Evidence criteria check: 1
- pain intensity · Distinct papers needing additional review: 1Evidence criteria check: 1
- perceptions of knee pain · Distinct papers needing additional review: 1Direction unclear: 1
- visual analogue scale (VAS) score · Distinct papers needing additional review: 1Direction unclear: 1
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Representative outcome and study details
Human studies reported between-group improvement in BML scores.
Single-ingredient studies · Human studies · Includes patient groups · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 51.5 evidence score includes 1 independent human studies and 0 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 70
Papers linked to this topic 12 · distinct papers 12 · papers with a confirmed human comparison 2 · papers needing additional review 9
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- BML scores: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- cartilage volume: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- cartilage volume loss: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- joint space narrowing: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- knee pain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- pain during activity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- pain intensity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- perceptions of knee pain: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- TKRs: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- visual analogue scale (VAS) score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
TKRs
No clear difference in this measurement was found between the compared groups.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
BML scores
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
cartilage volume loss
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
cartilage volume
No clear difference in this measurement was found between the compared groups.
Meta-analysis · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
pain during activity
The study reported improvement in this measurement.
Meta-analysis · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
joint space narrowing
The study needs further checking before its result can be interpreted.
Meta-analysis · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
knee pain
The study needs further checking before its result can be interpreted.
Meta-analysis · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
pain intensity
The study needs further checking before its result can be interpreted.
Meta-analysis · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
perceptions of knee pain
The study needs further checking before its result can be interpreted.
Controlled study in people · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Meta-analysis · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Review · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Review · Ingredient combination · Unspecified population
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Controlled study in people · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
visual analogue scale (VAS) score
The study needs further checking before its result can be interpreted.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Side effects and combination studies
No side-effect or combination findings are available to show from the collected papers. This does not establish safety.